Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (Review).
Int J Oncol
; 65(3)2024 Sep.
Article
in En
| MEDLINE
| ID: mdl-39129306
ABSTRACT
Alternative RNA splicing provides cells with transcriptomic and proteomic diversity by adding another layer of regulation to gene expression. Accumulating evidence has revealed that defects in alternative splicing contribute to a variety of features of cancer development, including the modulation of cancer heterogeneity, evasion of apoptosis of cancer cells, rewiring cancer metabolism and facilitating cancer metastasis via finetuning the epithelialtomesenchymal transition process. In this review, wellknown aberrant alternative splicing events associated with multiple aspects of cancer progression were presented based on available data obtained from an extensive literature search used to construct splicing regulatory networks for each of these events. The study aims to provide a more comprehensive understanding of cancerassociated splicing networks and more precise guidance for targeting these events for cancer treatment.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gene Expression Regulation, Neoplastic
/
Alternative Splicing
/
Epithelial-Mesenchymal Transition
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
Int J Oncol
Journal subject:
NEOPLASIAS
Year:
2024
Document type:
Article
Country of publication:
Greece